Eagle Pharmaceuticals, Inc. (EGRX)
USD 0.65
(0.0%)
USD 0.65
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 316.61 Million | 171.54 Million | 187.8 Million | 195.89 Million | 213.31 Million | 236.7 Million |
| Cost of Revenue | 94.93 Million | 42.18 Million | 45.46 Million | 60.89 Million | 61.91 Million | 57.18 Million |
| Gross Profit | 221.67 Million | 129.36 Million | 142.33 Million | 134.99 Million | 151.39 Million | 179.52 Million |
| Operating Expenses | 140.71 Million | 126.59 Million | 109.38 Million | 113.18 Million | 104.92 Million | 104.02 Million |
| Selling, General and Administrative Expenses | 106.62 Million | 75.32 Million | 78.59 Million | 76.37 Million | 60.5 Million | 71.41 Million |
| Research and Development Expenses | 34.08 Million | 51.27 Million | 30.78 Million | 36.81 Million | 44.41 Million | 32.6 Million |
| Other Expenses | - | -6.24 Million | -8.26 Million | 700 Thousand | 52.22 Million | 35.22 Million |
| Cost and Expenses | 235.65 Million | 168.77 Million | 154.84 Million | 174.07 Million | 166.84 Million | 161.2 Million |
| Operating Income | 53.45 Million | -2.91 Million | 25.25 Million | 21.81 Million | 36.61 Million | 73.99 Million |
| Interest Expense | 4.04 Million | 1.63 Million | 2.57 Million | 2.68 Million | 2.73 Million | 1.13 Million |
| Income Tax Expense | 25.79 Million | 4.07 Million | 10.68 Million | 7.68 Million | 2.13 Million | 21 Million |
| Earnings before Tax | 61.43 Million | -4.54 Million | 22.67 Million | 21.99 Million | 34.03 Million | 72.94 Million |
| Net Income | 35.64 Million | -8.62 Million | 11.98 Million | 14.31 Million | 31.9 Million | 51.94 Million |
| Earnings Per Share Basic | 2.76 | -0.66 | 0.89 | 1.04 | 2.16 | 3.44 |
| Earnings Per Share Diluted | 2.73 | -0.66 | 0.87 | 1.01 | 2.09 | 3.27 |
| Weighted Average Shares Outstanding | 12.93 Million | 13.05 Million | 13.48 Million | 13.75 Million | 14.76 Million | 15.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.06 Million | 13.05 Million | 13.77 Million | 14.13 Million | 15.27 Million | 15.9 Million |
| Gross Margin | 0.70 | 0.75 | 0.76 | 0.69 | 0.71 | 0.76 |
| EBIT Margin | 0.24 | 0.00 | 0.16 | 0.15 | 0.24 | 0.34 |
| Profit Margin | 0.11 | -0.05 | 0.06 | 0.07 | 0.15 | 0.22 |
| EBITDA | 77.5 Million | 2.76 Million | 30.02 Million | 28.17 Million | 40.44 Million | 77.82 Million |
| Earnings Before Tax Margin | 0.17 | -0.02 | 0.13 | 0.11 | 0.17 | 0.31 |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 64.64 Million | 66.3 Million | 316.61 Million | 60.69 Million | 65.9 Million | 74.13 Million |
| Cost of Revenue | 16.85 Million | 17.3 Million | 94.93 Million | 19.86 Million | 23.65 Million | 23.66 Million |
| Gross Profit | 47.78 Million | 49 Million | 221.67 Million | 40.83 Million | 42.25 Million | 50.47 Million |
| Operating Expenses | 37.48 Million | 37.23 Million | 140.71 Million | 31.36 Million | 32.78 Million | 48.26 Million |
| Selling, General and Administrative Expenses | 27.65 Million | 27.96 Million | - | 24.15 Million | 23.46 Million | 36.83 Million |
| Research and Development Expenses | 9.83 Million | 9.27 Million | - | 7.21 Million | 9.32 Million | 11.43 Million |
| Other Expenses | 247 Thousand | -238 Thousand | -15.75 Million | 5.5 Million | -7.91 Million | -7.76 Million |
| Cost and Expenses | 54.34 Million | 54.53 Million | 235.65 Million | 51.23 Million | 56.43 Million | 71.93 Million |
| Operating Income | 10.3 Million | 6.18 Million | 53.45 Million | 9.46 Million | -2.3 Million | 2.2 Million |
| Interest Expense | 1.44 Million | 1.51 Million | 4.04 Million | 1.98 Million | 1.59 Million | 552 Thousand |
| Income Tax Expense | 4.13 Million | 4.48 Million | 25.79 Million | 5.13 Million | 3.46 Million | 3.58 Million |
| Earnings before Tax | 9.29 Million | 10.23 Million | 61.43 Million | 13.3 Million | -45 Thousand | -5.86 Million |
| Net Income | 5.16 Million | 5.75 Million | 35.64 Million | 8.16 Million | -3.51 Million | -9.45 Million |
| Earnings Per Share Basic | 0.39 | 0.44 | - | 0.63 | -0.27 | -0.74 |
| Earnings Per Share Diluted | 0.39 | 0.44 | - | 0.62 | -0.27 | -0.74 |
| Weighted Average Shares Outstanding | 13.09 Million | 13.05 Million | 12.93 Million | 13.01 Million | 13.16 Million | 12.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.15 Million | 13.15 Million | 13.06 Million | 13.12 Million | 13.16 Million | 12.83 Million |
| Gross Margin | 0.74 | 0.74 | 0.70 | 0.67 | 0.64 | 0.68 |
| EBIT Margin | 0.17 | 0.18 | - | 0.25 | 0.02 | -0.05 |
| Profit Margin | 0.08 | 0.09 | 0.11 | 0.13 | -0.05 | -0.13 |
| EBITDA | 10.74 Million | 11.74 Million | - | 15.28 Million | 1.54 Million | -3.68 Million |
| Earnings Before Tax Margin | 0.16 | 0.09 | 0.17 | 0.16 | -0.03 | 0.03 |
600658
TINNARUBR
002224
PTNUF
TXGN
DORE